{
    "organizations": [],
    "uuid": "efc7139403543c336ccedb34538877fa62fcf2a6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-teva-says-co-lenders-entered-into/brief-teva-says-co-lenders-entered-into-certain-amendments-idUSFWN1PR19V",
    "ord_in_thread": 0,
    "title": "BRIEF-Teva Says Co, Lenders Entered Into Certain Amendments",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Teva Pharmaceutical Industries Ltd :\n* TEVA PHARMACEUTICAL INDUSTRIES SAYS ON FEBRUARY 1, 2018, CO, LENDERS ENTERED INTO CERTAIN AMENDMENTS - SEC FILING\n* TEVA PHARMACEUTICAL- IN RELATION WITH AMENDMENTS, COMMITMENTS UNDER REVOLVING CREDIT AGREEMENT SHALL BE REDUCED FROM $4.5 BILLION TO $3.0 BILLION Source text - bit.ly/2BN3nkE Further company coverage:\n ",
    "published": "2018-02-02T05:46:00.000+02:00",
    "crawled": "2018-02-02T12:51:25.038+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "teva",
        "pharmaceutical",
        "industry",
        "say",
        "february",
        "co",
        "lender",
        "entered",
        "certain",
        "amendment",
        "sec",
        "filing",
        "teva",
        "relation",
        "amendment",
        "commitment",
        "revolving",
        "credit",
        "agreement",
        "shall",
        "reduced",
        "billion",
        "billion",
        "source",
        "text",
        "company",
        "coverage"
    ]
}